UK government secures deal for 100 million flu vaccines from CSL Seqirus

The UK government has entered into an agreement with CSL (OTC:) Seqirus for the purchase of over 100 million doses of flu vaccines, in preparation for a potential future influenza outbreak. This development was announced on Tuesday by the UK Health Security Agency.

The agreement is designed as an advance purchase deal, conditional on the World Health Organization’s (WHO) declaration of a flu pandemic. In such a scenario, Britain will have the right to procure these vaccines, thus facilitating a swift response to protect public health.

The vaccines involved in this agreement are produced at CSL’s manufacturing facility in Liverpool.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.